115 related articles for article (PubMed ID: 2036240)
1. Uptake and retention of platinum in patients undergoing cisplatin therapy.
Jonson R; Börjesson J; Mattsson S; Unsgaard B; Wallgren A
Acta Oncol; 1991; 30(3):315-9. PubMed ID: 2036240
[TBL] [Abstract][Full Text] [Related]
2. A method for in vivo analysis of platinum after chemotherapy with cisplatin.
Jonson R; Mattsson S; Unsgaard B
Phys Med Biol; 1988 Jul; 33(7):847-57. PubMed ID: 3212044
[TBL] [Abstract][Full Text] [Related]
3. Initial measurements of platinum concentration in head and neck tumors using X-ray fluorescence.
Ali PA; Lewis DG; el-Sharkawi AM; al-Sadhan FA; Evans CJ; Hancock DA; Dutton J
Basic Life Sci; 1993; 60():281-4. PubMed ID: 8110128
[No Abstract] [Full Text] [Related]
4. Factors affecting platinum concentrations in human surgical tumour specimens after cisplatin.
Stewart DJ; Molepo JM; Green RM; Montpetit VA; Hugenholtz H; Lamothe A; Mikhael NZ; Redmond MD; Gadia M; Goel R
Br J Cancer; 1995 Mar; 71(3):598-604. PubMed ID: 7880744
[TBL] [Abstract][Full Text] [Related]
5. [Platinum concentrations in human tissue after administration of cisplatin].
Tochigi T; Ono K; Yoshikawa K; Hoshi S; Orikasa S; Imai Y
Gan To Kagaku Ryoho; 1988 Feb; 15(2):269-75. PubMed ID: 3341789
[TBL] [Abstract][Full Text] [Related]
6. Disposition and tumour concentrations of platinum in hypoalbuminaemic patients after treatment with cisplatin for cancer of the head and neck.
Holding JD; Lindup WE; Bowdler DA; Siodlak MZ; Stell PM
Br J Clin Pharmacol; 1991 Aug; 32(2):173-9. PubMed ID: 1931468
[TBL] [Abstract][Full Text] [Related]
7. Plane polarized x-ray fluorescence system for the in vivo measurement of platinum in head and neck tumours.
Ali PA; Al-Hussany AF; Bennett CA; Hancock DA; El-Sharkawi AM
Phys Med Biol; 1998 Aug; 43(8):2337-45. PubMed ID: 9725608
[TBL] [Abstract][Full Text] [Related]
8. In vivo X-ray fluorescence analysis with applications to platinum, gold and mercury in man--experiments, improvements, and patient measurements.
Börjesson J; Alpsten M; Huang S; Jonson R; Mattsson S; Thornberg C
Basic Life Sci; 1993; 60():275-80. PubMed ID: 8110127
[No Abstract] [Full Text] [Related]
9. Long-term pharmacokinetic behavior of platinum after cisplatin administration.
Gamelin E; Allain P; Maillart P; Turcant A; Delva R; Lortholary A; Larra F
Cancer Chemother Pharmacol; 1995; 37(1-2):97-102. PubMed ID: 7497604
[TBL] [Abstract][Full Text] [Related]
10. In vivo measurement of platinum in the kidneys using X-ray fluorescence.
Kadhim R; al-Hussany A; Ali PA; Hancock DA; el-Sharkawi AM
Ann N Y Acad Sci; 2000 May; 904():263-6. PubMed ID: 10865752
[TBL] [Abstract][Full Text] [Related]
11. Gamma camera imaging of platinum in tumours and tissues of patients after administration of 191Pt-cisplatin.
Areberg J; Björkman S; Einarsson L; Frankenberg B; Lundqvist H; Mattsson S; Norrgren K; Scheike O; Wallin R
Acta Oncol; 1999; 38(2):221-8. PubMed ID: 10227445
[TBL] [Abstract][Full Text] [Related]
12. Selective intra-arterial infusion of high-dose cisplatin in patients with advanced head and neck cancer results in high tumor platinum concentrations and cisplatin-DNA adduct formation.
Los G; Blommaert fA; Barton R; Heath DD; den Engelse L; Hanchett C; Vicario D; Weisman R; Robbins KT; Howell SB
Cancer Chemother Pharmacol; 1995; 37(1-2):150-4. PubMed ID: 7497585
[TBL] [Abstract][Full Text] [Related]
13. Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer.
Gietema JA; Meinardi MT; Messerschmidt J; Gelevert T; Alt F; Uges DR; Sleijfer DT
Lancet; 2000 Mar; 355(9209):1075-6. PubMed ID: 10744098
[TBL] [Abstract][Full Text] [Related]
14. Local distribution into brain tumor and pharmacokinetics of 4-pyridoxate diammine hydroxy platinum, a novel cisplatin derivative, after intracarotid administration in rats with 9L malignant glioma: simultaneous brain microdialysis study.
Tokunaga Y; Nakashima M; Sasaki H; Tomiyama N; Nakashima MN; Ichikawa M; Kaminogo M; Shibata S
Biol Pharm Bull; 2000 Dec; 23(12):1491-6. PubMed ID: 11145184
[TBL] [Abstract][Full Text] [Related]
15. Long-term platinum retention after platinum-based chemotherapy in testicular cancer survivors: a 20-year follow-up study.
Hjelle LV; Gundersen PO; Oldenburg J; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Bremnes RM; Haugnes HS
Anticancer Res; 2015 Mar; 35(3):1619-25. PubMed ID: 25750319
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects.
Hohnloser JH; Schierl R; Hasford B; Emmerich B
Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151
[TBL] [Abstract][Full Text] [Related]
17. The long-term retention of platinum in human tissues following the administration of cisplatin or carboplatin for cancer chemotherapy.
Tothill P; Klys HS; Matheson LM; McKay K; Smyth JF
Eur J Cancer; 1992; 28A(8-9):1358-61. PubMed ID: 1515251
[TBL] [Abstract][Full Text] [Related]
18. Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma.
Fichtinger-Schepman AM; Vendrik CP; van Dijk-Knijnenburg WC; de Jong WH; van der Minnen AC; Claessen AM; van der Velde-Visser SD; de Groot G; Wubs KL; Steerenberg PA
Cancer Res; 1989 Jun; 49(11):2862-7. PubMed ID: 2720647
[TBL] [Abstract][Full Text] [Related]
19. Comparison of platinum concentrations in human head and neck tumours following administration of carboplatin, iproplatin or cisplatin.
Hecquet B; Caty A; Fournier C; Lefebvre JL; Adenis L
Bull Cancer; 1987; 74(4):433-6. PubMed ID: 3311237
[TBL] [Abstract][Full Text] [Related]
20. Long-term platinum excretion in patients treated with cisplatin.
Schierl R; Rohrer B; Hohnloser J
Cancer Chemother Pharmacol; 1995; 36(1):75-8. PubMed ID: 7720180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
